Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail!

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Pope, Janet E
Nash, Peter
Fleischmann, Roy
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
License
Abstract

The ideal state for a patient with rheumatoid arthritis (RA) is sustained remission. Contemporary treatment strategies such as early initiation of DMARD(s), optimal methotrexate dosing and treating to a target with validated outcomes have improved the likelihood of remission in RA. Remission, however defined, is not always achieved and even less often will patients with RA maintain sustained remission over time.

Journal Title

Arthritis & Rheumatology

Conference Title
Book Title
Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2021 American College of Rheumatology. This is the peer reviewed version of the following article: Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail!, Arthritis & Rheumatology, 2021, which has been published in final form at https://doi.org/10.1002/art.41746. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)

Item Access Status
Note

This publication has been entered as an advanced online version in Griffith Research Online.

Access the data
Related item(s)
Subject

Clinical sciences

Persistent link to this record
Citation

Pope, JE; Nash, P; Fleischmann, R, Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail!, Arthritis & Rheumatology, 2021

Collections